Literature DB >> 30308047

Prevalence of hypothyroidism in patients with hyponatremia: A retrospective cross-sectional study.

Takanobu Nagata1, Shoko Nakajima2, Atsushi Fujiya3, Hiroshi Sobajima3, Makoto Yamaguchi1.   

Abstract

OBJECTIVE: Hypothyroidism has been suggested to be an uncommon cause of hyponatremia. However, little is known about the prevalence of hypothyroidism in patients with different levels of hyponatremia. The objective of this study was to investigate the prevalence of hypothyroidism among patients with hyponatremia of varying severity while taking into consideration potential confounders associated with thyroid function.
METHODS: All data on thyrotropin (TSH), free thyroxine (T4), and serum sodium (Na) levels were retrospectively collected from medical records at two Japanese tertiary hospitals. The main outcome measure was overt hypothyroidism, defined as TSH > 10.0 μIU/mL and free T4 < 1.01 ng/dL.
RESULTS: Of 71,817 patients, 964 patients (1.3%) had overt hypothyroidism. The prevalence of overt hypothyroidism in each category of hyponatremia (Na ≥136, 130-135, and ≤129 mEq/L) was 1.2% (787/65,051), 2.4% (124/5,254) and 3.5% (53/1,512), respectively. A significant increase in prevalence was observed as the severity of hyponatremia increased (P < 0.001 for trend). Multivariate logistic regression with adjustment for age, sex, kidney function, and serum albumin level showed that the odds ratios for overt hypothyroidism increased with increasing severity of hyponatremia when compared with Na ≥ 136 mEq/L (130-135 mEq/L: 1.43, 95% confidence interval [CI], 1.15 to 1.78, P = 0.001; ≤129 mEq/L: 1.87, 95% CI, 1.32 to 2.63, P < 0.001; P< 0.001 for trend).
CONCLUSION: The prevalence of overt hypothyroidism was significantly higher as the severity of hyponatremia progressed, even after adjusting for potential confounders. Hypothyroidism should be differentiated in patients with hyponatremia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30308047      PMCID: PMC6181416          DOI: 10.1371/journal.pone.0205687

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Hypothyroidism is often referred to as a cause of hyponatremia, but several reports have shown that the association between thyroid function and serum sodium levels is very weak and of marginal clinical relevance[1-6]. Retrospective cross-sectional analyses have shown that the prevalence of hyponatremia and distribution of serum sodium levels were similar among euthyroid and hypothyroid patients[1]. A recent review and clinical practice guideline for hyponatremia have mentioned that even though hypothyroidism is one possible cause of hyponatremia, it should only be attributed to severe hypothyroidism, as in myxedema coma[4,6,7]. However, past reports had simply compared the prevalence of hyponatremia between patients with and without hypothyroidism[1,5,8]. In addition, some confounders such as sex, age, kidney function, and serum albumin level, which are reported to be associated with thyroid function[9-12], were not considered. Furthermore, no information was available about the prevalence of hypothyroidism with varying severity of hyponatremia. The objective of the present retrospective cross-sectional study was to investigate the prevalence of hypothyroidism by severity of hyponatremia, and to clarify whether the association between the severity of hyponatremia and hypothyroidism is affected by confounding factors associated with thyroid function.

Materials and methods

The study protocol was approved by the ethics committee of Yokkaichi Municipal Hospital and Ogaki Municipal Hospital. The study was conducted in accordance with the Declaration of Helsinki. The ethics committee approved waiver of informed consent for this study. The approval number of Yokkaichi Municipal Hospital was 2017–8 and that of Ogaki Municipal Hospital was 20161222–4. All data on thyrotropin (TSH) levels between January 2008 and December 2017 were retrospectively collected from medical records at Yokkaichi Municipal Hospital in Yokkaichi, Japan, and Ogaki Municipal Hospital, in Ogaki, Japan. Both are tertiary hospitals in their respective medical districts. For each patient, initial TSH data during the study period and free thyroxine (T4) data from the same day were obtained. Patient age, sex, and levels of serum creatinine, blood urea nitrogen, potassium, chloride, total protein, albumin, and free triiodothyronine (T3) on the same day as TSH testing were also obtained. Next, we extracted the minimum serum sodium (Na) level within 3 days of TSH testing because TSH testing was unavailable at night and during holidays. Consequently, hyponatremia could have already been treated by the time of TSH testing. We excluded patients aged 17 years or younger. The reference ranges for TSH and free T4 were 0.27 to 4.20 μIU/mL and 1.01 to 1.79 ng/dL, respectively. Estimated glomerular filtration rate (eGFR) was calculated using the equation from the Japanese Society of Nephrology: eGFR (mL/min/1.73 m2) = 194 × serum creatinine-1.094 × age-0.287 × 0.739 (for female patients)[13]. We defined hypothyroidism as TSH > 4.20 μIU/mL, and overt hypothyroidism as TSH > 10.0 μIU/mL plus free T4 < 1.01 ng/dL. Hyponatremia was defined as Na ≤ 135 mEq/L. Hyponatremia was classified as mild (130–135 mEq/L) or moderate to profound (≤129 mEq/L) according to guideline[14].

Statistical analysis

Continuous variables were expressed as medians and interquartile ranges and compared using the Kruskal-Wallis test. Categorical variables were expressed as percentages and compared using Fisher’s exact test. Linear trends in proportions were assessed using the Cochran-Armitage test. Pearson’s correlation coefficients were used for correlation analysis. Univariate and multivariate logistic regression models were used to compute odds ratios and 95% confidence intervals (CIs) for hypothyroidism or overt hypothyroidism in each category of hyponatremia, with Na ≥ 136 mEq/L as the referent group. Multivariate models were adjusted for sex, age, eGFR, and serum albumin, which are factors that have previously been reported to be associated with thyroid function[9-12,15]. Univariate and multivariate linear trend tests were performed using each Na category as an ordinal variable. All P values were two-tailed, and P < 0.05 was considered statistically significant. All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan)[14], which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria).

Results

Overall, data from 71,817 patients were included in this study. Patient characteristics are shown in Table 1. In total, 4,710 patients (6.6%) had hypothyroidism and 964 patients (1.3%) had overt hypothyroidism. The proportion of patients with hypothyroidism among those with a Na level of ≥136 mEq/L, 130–135 mEq/L, and ≤129 mEq/L was 6.1% (3,975 patients), 10.3% (539 patients), and 13.0% (196 patients), respectively. The proportion of overt hypothyroidism in the same categories was 1.2% (787 patients), 2.4% (124 patients), and 3.5% (53 patients), respectively.
Table 1

Patient characteristics by severity of hyponatremia.

Serum sodium level
CharacteristicAll patients(n = 71,817)≥136 mEq/L(n = 65,051)130–135 mEq/L(n = 5,254)≤129 mEq/L(n = 1,512)P
Male sex, n (%)34785 (48.4)30927 (47.5)3026 (57.6)832 (55.0)< 0.001
Age, years66 [49, 76]65 [48, 75]72 [61, 81]75 [65, 82]< 0.001
Sodium, mEq/L140 [138, 142]140 [139, 142]134 [132, 135]126 [121, 128]< 0.001
Potassium, mEq/L4.2 [3.9, 4.4]4.2 [3.9, 4.4]4.2 [3.8, 4.6]4.2 [3.8, 4.7]< 0.001
Chloride, mEq/L105 [103, 107]105 [104, 107]100 [97, 103]93 [88, 97]< 0.001
Blood urea nitrogen, mg/dL14.9 [11.7, 19.3]14.7 [11.7, 18.9]16.9 [12.3, 25.2]16.4 [11.1, 26.2]< 0.001
Creatinine, mg/dL0.71 [0.60, 0.90]0.71 [0.60, 0.90]0.80 [0.60, 1.11]0.70 [0.52, 1.10]< 0.001
eGFR, mL/min/1.73m274.0 [57.8, 90.7]74.4 [58.8, 90.7]69.2 [45.9, 88.9]72.6 [46.4, 96.9]< 0.001
Total protein, g/dL7.10 [6.60, 7.50]7.10 [6.70, 7.50]6.60 [6.00, 7.30]6.40 [5.70, 7.10]< 0.001
Albumin, g/dL4.20 [3.79, 4.50]4.26 [3.88, 4.50]3.50 [3.00, 4.00]3.37 [2.77, 3.99]< 0.001
TSH, μIU/mL1.33 [0.83, 2.15]1.33 [0.84, 2.12]1.40 [0.78, 2.41]1.46 [0.82, 2.69]< 0.001
Free T3, pg/mL2.82 [2.42, 3.20]2.86 [2.47, 3.23]2.40 [1.91, 2.84]2.10 [1.68, 2.56]< 0.001
Free T4, ng/dL1.06 [0.94, 1.19]1.05 [0.94, 1.18]1.06 [0.92, 1.23]1.13 [0.94, 1.32]< 0.001

Categorical variables are expressed as the number (%) and continuous variables are expressed as the median [interquartile range]

eGFR, estimated glomerular filtration rate; TSH, thyrotropin; T3, triiodothyronine; T4, thyroxine.

Categorical variables are expressed as the number (%) and continuous variables are expressed as the median [interquartile range] eGFR, estimated glomerular filtration rate; TSH, thyrotropin; T3, triiodothyronine; T4, thyroxine. The Cochran-Armitage trend test showed a significant increase in the proportion of patients with hypothyroidism and overt hypothyroidism as the severity of hyponatremia increased (both P < 0.001). The Pearson’s correlation coefficient for TSH and Na for the entire study population was -0.021 (95% CI, -0.028 to -0.013, P < 0.001) (Fig 1). Among patients with hypothyroidism and overt hypothyroidism, the values were -0.007 (95% CI, -0.035 to 0.021, P = 0.624) and 0.029 (95% CI, -0.034 to 0.092, P = 0.365) (Fig 1). A statistically significant but weak correlation was observed between TSH and Na in the entire study population. No statistically significant relationship was observed between TSH and Na among patients with hypothyroidism and overt hypothyroidism, respectively.
Fig 1

Correlation between thyrotropin and serum sodium levels in all patients (a), patients with hypothyroidism (b), and overt hypothyroidism (c). Pearson’s correlation coefficient: a, -0.021 (95% confidence interval [CI], -0.028 to -0.013, P < 0.001); b, -0.007 (95% CI, -0.035 to 0.021, P = 0.624); c, 0.029 (95% CI, -0.034 to 0.092, P = 0.365). Hypothyroidism was defined as TSH > 4.20 μIU/mL. Overt hypothyroidism was defined as TSH > 10.0 μIU/mL plus free T4 < 1.01 ng/dL.

Correlation between thyrotropin and serum sodium levels in all patients (a), patients with hypothyroidism (b), and overt hypothyroidism (c). Pearson’s correlation coefficient: a, -0.021 (95% confidence interval [CI], -0.028 to -0.013, P < 0.001); b, -0.007 (95% CI, -0.035 to 0.021, P = 0.624); c, 0.029 (95% CI, -0.034 to 0.092, P = 0.365). Hypothyroidism was defined as TSH > 4.20 μIU/mL. Overt hypothyroidism was defined as TSH > 10.0 μIU/mL plus free T4 < 1.01 ng/dL. The unadjusted and adjusted odds ratios for hypothyroidism and overt hypothyroidism in each hyponatremia category are shown in Table 2. The adjusted odds ratios for hypothyroidism among patients with Na of 130–135 mEq/L and ≤129 mEq/L compared with Na ≥136 mEq/L were 1.11 (95% CI, 0.99 to 1.24, P = 0.054) and 1.32 (95% CI, 1.11 to 1.58, P = 0.003), respectively. The odds ratios for overt hypothyroidism were 1.43 (95% CI, 1.15 to 1.78, P = 0.001) and 1.87 (95% CI, 1.32 to 2.63, P < 0.001). A significant trend of increase in adjusted odds ratios was observed among patients with both hypothyroidism and overt hypothyroidism (P < 0.001 for trend).
Table 2

Associations between hyponatremia category and hypothyroidism.

Serum sodium level
CharacteristicOverall(n = 71,817)≥136 mEq/L(n = 65,051)130–135 mEq/L(n = 5,254)≤129 mEq/L(n = 1,512)P for trend
Hypothyroidism, n (%)4710 (6.6)3975 (6.1)539 (10.3)196 (13.0)
UnadjustedReferent1.75 (1.59–1.93)2.28 (1.95–2.67)< 0.001
Model 1Referent1.42 (1.29–1.57)1.77 (1.50–2.09)< 0.001
Model 2Referent1.11 (0.99–1.24)1.32 (1.11–1.58)< 0.001
Overt hypothyroidism, n (%)964 (1.3)787 (1.2)124 (2.4)53 (3.5)
UnadjustedReferent1.97 (1.61–2.38)2.96 (2.19–3.94)< 0.001
Model 1Referent1.54 (1.26–1.89)2.37 (1.74–3.21)< 0.001
Model 2Referent1.43 (1.15–1.78)1.87 (1.32–2.63)< 0.001

Hypothyroidism was defined as thyrotropin > 4.20 μIU/mL.

Overt hypothyroidism was defined as thyrotropin > 10.0 μIU/mL and free thyroxine < 1.01 ng/dL.

Model 1 adjusted for age, sex, and estimated glomerular filtration rate.

Model 2 adjusted for variables in Model 1 and serum albumin level.

Hypothyroidism was defined as thyrotropin > 4.20 μIU/mL. Overt hypothyroidism was defined as thyrotropin > 10.0 μIU/mL and free thyroxine < 1.01 ng/dL. Model 1 adjusted for age, sex, and estimated glomerular filtration rate. Model 2 adjusted for variables in Model 1 and serum albumin level.

Discussion

This retrospective cross-sectional study investigated the prevalence of hypothyroidism in patients with hyponatremia. The correlation between TSH and Na levels was very weak, but the prevalence of hypothyroidism and overt hypothyroidism were significantly higher among patients with hyponatremia compared with patients with Na ≥ 136 mEq/L. Furthermore, a significant trend of increase in the prevalence of hypothyroidism and overt hypothyroidism was observed as the severity of hyponatremia increased, even after adjusting for potential confounders associated with thyroid function. Past studies have reported a weak association between TSH and Na levels. Wolf et al. reported a very mild positive correlation between TSH and Na levels (-0.022; P = 0.046) in patients with newly diagnosed hypothyroidism in a single-center retrospective analysis[5]. They concluded that this weak association was not clinically significant. Schwarz et al. reported that TSH and Na levels were not significantly correlated (-0.02; P > 0.05) in patients whose TSH and Na levels were examined in the emergency department in a single center retrospective analysis[8]. The correlation coefficients in the present study were similar. The reason for this weak association could be that most patients with hypothyroidism were normonatremic. Therefore, the correlation could be weakened because the majority of patients had normonatremia when TSH and Na levels were analyzed as continuous variables. However, we thought that it was necessary to investigate the prevalence of hypothyroidism in patients with hyponatremia to understand the direction of the causal relationship. It has been reported that there was no significant difference in distribution of Na levels between hypothyroid patients and controls, but every 10 mU/L rise in TSH is associated with a 0.14 mmol/L fall in Na[2]. Consequently, a recent review and clinical practice guideline for hyponatremia suggested that hypothyroidism rarely causes hyponatremia and hyponatremia should not be attributed to hypothyroidism except in cases of severe hypothyroidism, such as myxedema coma[4,6,7]. However, the present study showed that the prevalence of hypothyroidism and overt hypothyroidism in patients with hyponatremia tended to increase as the severity of hyponatremia increased. This result indicated that some patients with hyponatremia could have concomitant hypothyroidism. This result seemed plausible given the pathophysiology of hyponatremia in patients with hypothyroidism. The putative mechanism by which hypothyroidism affects Na level is that hypothyroidism induces decreased cardiac output, which results in compensatory elevation of antidiuretic hormone levels and decreased GFR[16,17]. That may induce free water retention and decrease excretion by decreasing water delivery to the diluting segment of the nephron[6,18]. It is therefore reasonable that hypothyroidism could be a cause of hyponatremia, if not alone, even without severe hypothyroidism did not exist. One strength of the present study was that confounders that could affect the prevalence of hypothyroidism were considered. An epidemiologic study revealed that hypothyroidism was more common in females and elderly individuals[10], and several reports have shown a higher prevalence of hypothyroidism in patients with chronic kidney disease[11,19]. In addition, it has been reported that serum albumin levels are significantly correlated with thyroid hormone levels[9]. Since the association between hyponatremia and hypothyroidism was significant even after adjusting for these factors, the results of present study can be considered more convincing. This study has several limitations. First, this was a retrospective study. Since all TSH and free T4 testing in the present study was performed in patients who were suspected to have thyroid disorder by their attending physicians, the actual prevalence of hypothyroidism in patients with hyponatremia remains unknown. Second, patients had different comorbidities of various etiologies that could have caused hyponatremia, but patients’ medical records were not reviewed in this study. Third, information about the use of medications that could cause hyponatremia, such as diuretics, was not available because TSH testing occurred during the first visit for most patients. Thus, information about medications prescribed by other clinics could not be obtained. Forth, we could not investigate the causality between hypothyroidism and hyponatremia because of the cross-sectional study design. A prospective and longitudinal study is needed to clarify these issues.

Conclusion

Although the correlation between TSH and Na was very weak, the prevalence of overt hypothyroidism increased significantly as the severity of hyponatremia progressed. Furthermore, the association remained even after adjusting for potential confounders associated with thyroid function. Thus, hypothyroidism should be differentiated in patients with hyponatremia.

Anonymous data set of 71817 patients.

(CSV) Click here for additional data file.
  19 in total

1.  Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study.

Authors:  Bjørn Olav Asvold; Trine Bjøro; Lars J Vatten
Journal:  Eur J Endocrinol       Date:  2010-10-07       Impact factor: 6.664

2.  The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study.

Authors:  Maria H Warner; Stephen Holding; Eric S Kilpatrick
Journal:  Clin Endocrinol (Oxf)       Date:  2006-05       Impact factor: 3.478

3.  'Dos and don'ts' in the management of hyponatremia.

Authors:  Simon Aylwin; Volker Burst; Alessandro Peri; Isabelle Runkle; Nicholas Thatcher
Journal:  Curr Med Res Opin       Date:  2015-09-04       Impact factor: 2.580

Review 4.  Hypothyroidism.

Authors:  Layal Chaker; Antonio C Bianco; Jacqueline Jonklaas; Robin P Peeters
Journal:  Lancet       Date:  2017-03-20       Impact factor: 79.321

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Eur J Endocrinol       Date:  2016-08-02       Impact factor: 6.664

6.  Hypothyroidism and Hyponatremia: Rather Coincidence Than Causality.

Authors:  Peter Wolf; Hannes Beiglböck; Sabina Smaijs; Thomas Wrba; Susanne Rasoul-Rockenschaub; Rodrig Marculescu; Alois Gessl; Anton Luger; Yvonne Winhofer; Michael Krebs
Journal:  Thyroid       Date:  2017-04-19       Impact factor: 6.568

7.  The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

Authors:  M P Vanderpump; W M Tunbridge; J M French; D Appleton; D Bates; F Clark; J Grimley Evans; D M Hasan; H Rodgers; F Tunbridge
Journal:  Clin Endocrinol (Oxf)       Date:  1995-07       Impact factor: 3.478

8.  Thyroid function and serum electrolytes: does an association really exist?

Authors:  Christoph Schwarz; Alexander Benedikt Leichtle; Spiros Arampatzis; Georg Martin Fiedler; Heinz Zimmermann; Aristomenis Konstantinos Exadaktylos; Gregor Lindner
Journal:  Swiss Med Wkly       Date:  2012-09-17       Impact factor: 2.193

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.

Authors:  Michel Chonchol; Giuseppe Lippi; Gianluca Salvagno; Giacomo Zoppini; Michele Muggeo; Giovanni Targher
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 8.237

View more
  3 in total

1.  Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure.

Authors:  Haku Tanaka; Fumihiko Nishimura; Kenta Nakase; Miho Kakutani; Shohei Yokoyama; Takayuki Morimoto; Taekyun Kim; Young-Soo Park; Ichiro Nakagawa; Shuichi Yamada; Kentaro Tamura; Ryosuke Matsuda; Yasuhiro Takeshima; Masashi Kotsugi; Hiroyuki Nakase
Journal:  Endocrine       Date:  2022-08-19       Impact factor: 3.925

2.  PES Syndrome Presenting as Severe Hyponatremia in an Asymptomatic Septuagenarian.

Authors:  Rahul Pansare; Sangeetha Nanthabalan
Journal:  Case Rep Endocrinol       Date:  2021-01-05

3.  Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma.

Authors:  Jing-Jia Cao; Can-Hua Yun; Juan Xiao; Yong Liu; Wei Wei; Wei Zhang
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.